Literature DB >> 8475083

The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

H Auchincloss1, R Lee, S Shea, J S Markowitz, M J Grusby, L H Glimcher.   

Abstract

In vitro studies have revealed several pathways by which T cells can respond to alloantigens, including CD4+ direct responses to allogeneic class II antigens, CD8+ direct responses to allogeneic class I antigens, and CD4+ "indirect" responses to peptides of alloantigens presented in association with responder class II molecules. In vivo studies of skin graft rejection, however, have so far provided clear evidence for the contribution of only the two direct pathways and not for indirect recognition. We have used major histocompatibility complex class II-deficient mice as donors to test the role of indirect recognition in rejection of skin grafts. Class II-deficient skin was always rejected without delay by normal recipients. Removal of recipient CD8+ cells (to leave the animals dependent on CD4+ function) or depletion of recipient CD4+ cells revealed that CD4+ cells were usually involved and sometimes absolutely required in this rapid rejection. Since the donor grafts lacked class II antigens, the CD4+ cells must have recognized donor antigens presented in association with recipient class II molecules. These results therefore indicate that indirect recognition can initiate rapid skin graft rejection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475083      PMCID: PMC46302          DOI: 10.1073/pnas.90.8.3373

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

3.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  B lymphocyte development and activation independent of MHC class II expression.

Authors:  J S Markowitz; P R Rogers; M J Grusby; D C Parker; L H Glimcher
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

5.  Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.

Authors:  M J Bevan
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

6.  Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses.

Authors:  A B Cosimi; R C Burton; P C Kung; R Colvin; G Goldstein; J Lifter; W Rhodes; P S Russell
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients.

Authors:  K M Bowen; L Andrus; K J Lafferty
Journal:  Diabetes       Date:  1980       Impact factor: 9.461

8.  Effect of organ culture on the survival of thyroid allografts in mice.

Authors:  K J Lafferty; A Bootes; G Dart; D W Talmage
Journal:  Transplantation       Date:  1976-08       Impact factor: 4.939

9.  Evidence for major histocompatibility complex restriction in transplantation immunity.

Authors:  W K Silvers; H L Fleming; A Naji; C F Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats.

Authors:  S T Bartlett; A S Jennings; C Yu; A Naji; C F Barker; W K Silvers
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  64 in total

1.  CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

Authors:  B A Pietra; A Wiseman; A Bolwerk; M Rizeq; R G Gill
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  A rendezvous before rejection: where do T cells meet transplant antigens?

Authors:  David M Briscoe; Mohamed H Sayegh
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

3.  Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism.

Authors:  Kenneth K Wong; Matthew J Carpenter; Lesley L Young; Susan J Walker; Grahame McKenzie; Alyson J Rust; George Ward; Laura Packwood; Karen Wahl; Luc Delriviere; Gerard Hoyne; Paul Gibbs; Brian R Champion; Jonathan R Lamb; Margaret J Dallman
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 4.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

5.  A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.

Authors:  Todd J Grazia; Biagio A Pietra; Zachary A Johnson; Brian P Kelly; Robert J Plenter; Ronald G Gill
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 6.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

7.  Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Santosh S Kale; Katherine B Santosa; Daniel A Hunter; Philip Johnson; Ying Yan; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

8.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

9.  The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.

Authors:  M J Weiss; D A Guenther; J D Mezrich; H Sahara; C Y Ng; A J Meltzer; J K Sayre; M E Cochrane; A C Pujara; S L Houser; D H Sachs; B R Rosengard; J S Allan; G Benichou; J C Madsen
Journal:  Am J Transplant       Date:  2009-01       Impact factor: 8.086

10.  Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.

Authors:  Maria Koulmanda; Manoj Bhasin; Lauren Hoffman; Zhigang Fan; Andi Qipo; Hang Shi; Susan Bonner-Weir; Prabhakar Putheti; Nicolas Degauque; Towia A Libermann; Hugh Auchincloss; Jeffrey S Flier; Terry B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.